Market Cap : 842 M | Enterprise Value : 820.2 M | PE Ratio : 23.05 | PB Ratio : 10.33 |
---|
NAS:NRC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:NRC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
National Research's Earnings per Share (Diluted) for the three months ended in Mar. 2022 was $0.34. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 was $1.45.
National Research's EPS (Basic) for the three months ended in Mar. 2022 was $0.34. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2022 was $1.45.
National Research's EPS without NRI for the three months ended in Mar. 2022 was $0.34. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2022 was $1.45.
During the past 12 months, National Research's average EPS without NRIGrowth Rate was 7.40% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 12.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 28.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 12.80% per year.
During the past 13 years, National Research's highest 3-Year average EPS without NRI Growth Rate was 62.60% per year. The lowest was -50.90% per year. And the median was 11.90% per year.
The historical data trend for National Research's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, National Research's Earnings per Share (Diluted), along with its competitors' market caps and Earnings per Share (Diluted) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, National Research's Earnings per Share (Diluted) distribution charts can be found below:
* The bar in red indicates where National Research's Earnings per Share (Diluted) falls into.
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
National Research's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2021 is calculated as
Diluted Earnings Per Share (A: Dec. 2021 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Diluted Average) |
= | (37.466 | - | 0) | / | 25.640 | |
= | 1.46 |
National Research's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2022 is calculated as
Diluted Earnings Per Share (Q: Mar. 2022 ) | = | (Net Income | - | Preferred Dividends | / | Shares Outstanding (Diluted Average) |
= | (8.539 | - | 0) | / | 25.390 | |
= | 0.34 |
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.45
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Thank you for viewing the detailed overview of National Research's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Jackson Steven D. | officer: President | C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 |
Martin Joann M | director | 6221 ANDREW COURT LINCOLN NE 68512 |
Nunnelly John N | director | P.O. BOX 2175 AMHERST MA 01004 |
Karas Kevin R | officer: SVP Finance, CFO, Treas & Secy | C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 |
Berwick Donald M | director | C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 |
Mowry Barbara | director | P.O. BOX 103115 DENVER CO 80250 |
Amandla Mk Trust | 10 percent owner | C/O THE BRYN MAWR TRUST COMPANY OF DELAW 20 MONTCHANIN RD, SUITE 100 GREENVILLE DE 19807 |
Hays Michael D. | director, officer: CEO | C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 |
K/i/e Trust Under Agreement 10/24/18 | 10 percent owner | C/O BESSEMER TRUST COMPANY OF DELAWARE 1007 N. ORANGE ST., SUITE 1450 WILMINGTON DE 19801 |
Endacott Kent E. | 10 percent owner | C/O WOODS & AITKEN LLP 301 SOUTH 13TH STREET, SUITE 500 LINCOLN NE 68508 |
Beans Patrick E | director, officer: CFO and Secretary | AMANDLA LLC 709 PIER 2 LINCOLN NE 68528 |
Warden Gail L | director | 250 WASHINGTON RD GROSSE POINTE MI 48230 |
Henricks Susan L | officer: President and COO | C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 |
Schorr Paul C Iii | director | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: SCHORR PAUL C III a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
Peetz Jeffery T | 10 percent owner | WOODS & AITKEN LLP 301 SOUTH 13TH STREET, SUITE 500 LINCOLN NE 68508 |
Other Sources
By Seekingalpha 2022-02-09